Deutsche Bank raised its rating on Johnson & Johnson (NYSE: JNJ ) from Hold to Buy and increased its price target from $75 to $82. Deutsche Bank commented, "For the past several years, JNJ has weathered through patent expirations, a general slowdown in utilization trends, and challenges with its